Pinelli Mirko

Pinelli Mirko

Auto-generated profile, based on publicly available information

Pinelli Mirko


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2022 in Qeios Preprints
Verified
Preprint
Open access
PDF file
DBDavide Baiamonte
Davide Baiamonte
SASilvia Altomare
Silvia Altomare
RGRosa Giaimo
Rosa Giaimo
MVMarco Vella
Marco Vella
PMPiero Mannone
Piero Mannone
Alchiede SimonatoAlchiede Simonato
Alchiede Simonato
Sepsis is one of the most dangerous post-operative complications. Recently, Monocyte Distribution Width (MDW), a blood test parameter able to measure morphological changes in monocytes, has been proposed and investigated as a new promising biomarker of sepsis. The aim of our study was to evaluate if MDW can be influenced by surgery to better understand if it could be use as a sepsis marker. All clinical and laboratories data were collected of all patients admitted from April to August 2021 to the Unit of Urology of our Department for elective kidney and ureteral stones surgery. The blood samples collected to evaluate MDW of each patient were analyzed on the UniCel DxH 900 analyzer (Beckman Coulter, Inc., USA), with an MDW value of 23 considered as significative value. Times of collection of blood samples were before surgery (BS), after surgery (AS) and at discharge time (DT) In all 66 patients enrolled in this study, while White Blood Cells (WBC) significantly increased after surgery (BS:7.95x109/L vs AS:11.4x109/L; p<0.001) with a trend to normalization at discharge (AS:11.40x109/L vs DT:9.90x109/L; p:0.021), there were no statistically significative differences for MDW (BS:17.6 vs AS:18.1; p:1) before and after surgery, as well comparing before surgery and at the time of discharge (BS:17.6 vs DT:18.5; p:0.237). In conclusion, MDW is not affected by surgical procedures and is easily measurable when compared to other biomarkers, considering that is part of a routine CBC. For these reasons, MDW could be a valid, cost-effective and fast biomarker to predict the risk of post-operative sepsis in elective surgery

8 January 2022 in Qeios Preprints
Verified
Preprint
Open access
PDF file
Alchiede SimonatoAlchiede Simonato
Alchiede Simonato
PMPinelli Mirko
Pinelli Mirko
GTGabriele Tulone
Gabriele Tulone
MVMarco Vella
Marco Vella
RGRosa Giaimo
Rosa Giaimo
NPNicola Pavan
Nicola Pavan
Surgery is the curative treatment for localized Renal Cancer Carcinoma (RCC). Nephron sparing surgery is the recommended treatment modality in patients with T1 tumors based on oncological and functional outcomes [1]. Patients with stage T1a renal cancer who have undergone conservative surgery have demonstrated better survival and functional outcomes [2]. Renorrhaphy and resection technique are important for the preservation of the renal function. To date no technique is clearly preferable, and the choice can be made based on preference and experience of the surgeon [5]. The criss-cross technique guarantees excellent haemostasis by limiting the insult on healthy renal parenchyma.

8 January 2022 in Qeios Preprints
Verified
Preprint
Open access
PDF file
PMPiero Mannone
Piero Mannone
RGRosa Giaimo
Rosa Giaimo
DBDavide Baiamonte
Davide Baiamonte
GGGianpaolo Di Gregorio
Gianpaolo Di Gregorio
GTGabriele Tulone
Gabriele Tulone
Alchiede SimonatoAlchiede Simonato
Alchiede Simonato
Ureteroscopy (URS) represents the most used procedure in the treatment of urolithiasis, conversely ureteral stenting before URS is still a topic of scientific discussion. The aim of our study is to evaluate the possible benefits and uses of pre-stenting and if it can be used in the everyday practice. In our retrospective observational study, we collected data of patients undergoing URS for ureteral and renal lithiasis from January 2018 to December 2020 at our Department. Patients were stratified by procedure (ureterolithotripsy or URSL vs retrograde intrarenal surgery or RIRS) and by pre-stenting. We collected the patients' clinical characteristics and the timing of pre-stenting insertion. As outcomes variables, we analyzed the stone free rate (SFR), operating times (OT) and short-term complications. 244 patients were included in the study, 84 had undergone pre-stenting with a mean of 44.3±42.7 days before surgery, while 160 did not. Regarding OT there are no differences in URSL and in the RIRS of stones in the renal pelvis; considering the RIRS of caliceal stones it is observed how the OT are lower in pre-stenting patients undergoing RIRS of caliceal stones (mean 79.29±34.7 vs 91.08±53.8 mins, p=0.1) and in case of multiple caliceal stones (mean 83.24±31.2 vs 103.53±48.6 mins, p=0.1). No differences were reported in the SFR for every URSL subgroups while it is higher in patients undergoing RIRS with a pre-stenting (85% vs 75%, p=0.08). Regarding the short term complications, in the pre-stenting group fewer cases of post-operative pain (20.4% vs 39.6% p<0.02) and hematuria (14.8% vs 28.3% p=0.08) were reported. Our study is in accordance with the indications of guidelines which advise against the routine use of pre-stenting before URS. RIRS deserve a separate evaluation and our study, although considering the routine use of pre-stenting unnecessary, recognize its usefulness in achieving SFR and reducing intraoperative complications.